Extended-Duration Low-Intensity Apixaban to Prevent Recurrence in Patients with Provoked Venous Thromboembolism and Enduring Risk Factors: Rationale and Design of the HI-PRO Trial.
Thromb Haemost
; 122(6): 1061-1070, 2022 06.
Article
in En
| MEDLINE
| ID: mdl-34530470
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pulmonary Embolism
/
Venous Thromboembolism
Type of study:
Clinical_trials
/
Diagnostic_studies
/
Etiology_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Thromb Haemost
Year:
2022
Document type:
Article
Affiliation country: